ADDvise signs Letter of Intent to acquire Kolplast CI S.A.

08-05-2023   Regulatory press release

ADDvise has signed a Letter of Intent with the shareholders of Kolplast CI S.A. (”Kolplast”) regarding an acquisition of all shares in Kolplast.

Kolplast is a Brazilian manufacturer of MedTech equipment based in São Paulo, Brazil. The company produces disposable medical devices, MedTech equipment, laboratory equipment, and liquid-based cytology products. The company is the market leader in Brazil with over 8,000 active clients. Several of the company’s products are registered for sale in the US and Europe.

The company’s revenue for the full year 2022 amounted to BRL 100.3 million with an adjusted EBITDA of BRL 28.1 million, corresponding to an adjusted EBITDA margin of 28 percent.

The purchase price for Kolplast amounts to an initial payment of BRL 160 million, and three potential earn-outs of BRL 50 million in total.

The acquisition will be financed with own funds and loans. ADDvise assesses that the acquisition will have a positive impact on ADDvise earnings per share during the financial year 2023.

The acquisition is subject to a due diligence and that the parties agree to enter into a share purchase agreement. The share purchase agreement and completion of the acquisition is scheduled to be completed during the second half of 2023.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

Hanna Myhrman, General Counsel
+46 709-82 92 23

Important information

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on May 8, 2023, at 06:30 CEST.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business - both geographically and product-wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB, +46 8 503 015 50,,is the Company's Certified Adviser. Additional information is available at



Latest press releases

ADDvise increases long-term financial targets


The Board of ADDvise Group AB has decided to update the long-term financial targets for EBITDA margin and revenue growth based on the strong financial performance and the visibility on the upcoming quarters. The EBITDA margin target has been increased from 20% to 28 % and the annual growth target from 25% to 30 %.…

ADDvise announces early redemption of existing bonds 2021/2024


ADDvise Group AB (publ) (the “Company”) announces today that it will redeem in full its outstanding bond loan with ISIN SE0015222088 (the “Bonds” and “Early Redemption”) subject to the successful issuance of new bonds as announced by the Company through a press release on 11 May 2023. Provided that the conditions for Early Redemption are…

ADDvise extends the agreement with Laborie at a value of SEK 48 million


ADDvise Group’s subsidiary Sonesta Medical AB extends the agreement with Laborie Medical Technologies (“Laborie”). The agreement is giving Laborie the right to sell Sonesta Medical’s urology- and gynecology patient positioning equipment and video fluoroscopy tables worldwide, with an exclusive right to distribute in USA and some European countries. Laborie commits to a minimum volume of…